Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-01-02 @ 2:44 PM
Study NCT ID:
NCT04389632
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2020-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor:
Seagen, a wholly owned subsidiary of Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma, Non-Small Cell Lung | View |
| None | Squamous Cell Carcinoma of Head and Neck | View |
| None | HER2 Negative Breast Neoplasms | View |
| None | Esophageal Squamous Cell Carcinoma | View |
| None | Esophageal Adenocarcinoma | View |
| None | Gastroesophageal Junction Adenocarcinoma | View |
| None | Ovarian Neoplasms | View |
| None | Cutaneous Squamous Cell Cancer | View |
| None | Exocrine Pancreatic Adenocarcinoma | View |
| None | Urinary Bladder Neoplasms | View |
| None | Uterine Cervical Neoplasms | View |
| None | Stomach Neoplasms | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | NSCLC | View |
| None | HNSCC | View |
| None | cSCC | View |
| None | ESCC | View |
| None | EAC | View |
| None | GEJ | View |
| None | HGSOC | View |
| None | Advanced HER2-Negative Breast Cancer | View |
| None | High Grade Serous Ovarian Cancer | View |
| None | Non-Small Cell Lung Cancer | View |
| None | Head and Neck Squamous Cell Cancer | View |
| None | Esophageal Cancer | View |
| None | Bladder Cancer | View |
| None | Cervical Cancer | View |
| None | Gastric Cancer | View |
| None | Seattle Genetics | View |